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computed tomography angiography has a substantial role in the diagnostic workup of patients with acute
chest pain and a doubtful TTS diagnosis to rule out other medical conditions. It can be considered as
a non-invasive appropriate alternative to coronary angiography in several clinical scenarios. Although
the role of nuclear imaging in TTS has not yet been well established, the combination of perfusion
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Abstract
Takotsubo syndrome (TTS) is a complex and still poorly recognized heart disease with a wide spectrum of possible clinical 
presentations. Despite its reversibility, it is associated with serious adverse in-hospital events and high complication rates 
during follow-up. Multimodality imaging is helpful for establishing the diagnosis, guiding therapy, and stratifying prognosis 
of TTS patients in both the acute and post-acute phase. Echocardiography plays a key role, particularly in the acute care set-
ting, allowing for the assessment of left ventricular (LV) systolic and diastolic function and the identification of the typical 
apical-midventricular ballooning pattern, as well as the circumferential pattern of wall motion abnormalities. It is also useful 
in the early detection of complications (i.e. LV outflow tract obstruction, mitral regurgitation, right ventricular involvement, 
LV thrombi, and pericardial effusion) and monitoring of systolic function recovery. Left ventriculography allows the evalu-
ation of LV function and morphology, identifying the typical TTS patterns when echocardiography is not available or wall 
motion abnormalities cannot be properly assessed with ultrasound. Cardiac magnetic resonance provides a more comprehen-
sive depiction of cardiac morphology and function and tissue characterization and offers additional value to other imaging 
modalities for differential diagnosis (myocardial infarction and myocarditis). Coronary computed tomography angiography 
has a substantial role in the diagnostic workup of patients with acute chest pain and a doubtful TTS diagnosis to rule out 
other medical conditions. It can be considered as a non-invasive appropriate alternative to coronary angiography in several 
clinical scenarios. Although the role of nuclear imaging in TTS has not yet been well established, the combination of perfu-
sion and metabolic imaging may provide useful information on myocardial function in both the acute and post-acutephase.
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Introduction
Takotsubo syndrome (TTS), also known as takotsubo car-
diomyopathy, stress-induced cardiomyopathy, or apical 
ballooning syndrome, is an acute and transient heart fail-
ure syndrome originally reported by Dr Sato in 1991 in a 
Japanese textbook and by Pavin et al. in Europe in 1997 
[1, 2]. Chest pain and/or dyspnoea are the most common 
symptoms at presentation, whereas diaphoresis and syncope 
are less frequently observed [3]. TTS generally occurs in 
post-menopausal women, though in several registries and 
case series up to 10% of TTS patients are male. Although 
stressor events (emotional or physical) usually trigger the 
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clinical onset of TTS, in about one-third of cases TTS has 
also been described without a preceding trigger.
Recently, a classification of TTS according to the type of 
triggering event has been proposed (Table 1) [4].
Electrocardiographic abnormalities (ST-T elevation in 
the majority of cases) resembling those detectable in acute 
coronary syndromes are common, as well as increased bio-
markers reflecting myocyte damage despite unobstructed 
coronary arteries. For this reason, TTS has been classified 
as ‘myocardial injury’ in the last universal definition of myo-
cardial infarction and categorized as myocardial infarction 
with non-obstructive coronary arteries (MINOCA) [4]. The 
pathophysiology of TTS is still unclear. Neuroendocrine, 
metabolic, genetic, and inflammatory factors via increased 
adrenergic stimulation and high level of catecholamine 
release seem to be involved in the genesis of the revers-
ible myocardial stunning associated with this fascinating 
syndrome [3]. Initially, multivessel coronary spasm was 
suspected as a possible cause of this unique wall motion 
defect, typically characterized by apical ballooning. Iga et al. 
described the first echocardiographic findings in eight cases 
with transient left ventricular (LV) segmental asynergy and 
suggested asynergy was unrelated to coronary artery dis-
ease [6]. Now, it is well recognized that a ‘takotsubo-like’ 
appearance represents only a part of this syndrome and many 
variant forms have been reported [7–9]. Despite its transient 
nature, the acute phase of TTS is characterized by a sub-
stantial incidence of adverse events such as acute heart fail-
ure, cardiogenic shock, and arrhythmias, and considerable 
in-hospital death (4–5%) [10, 11]. Even at long term, TTS 
recurrence, cardiac and non-cardiac disorders, and increased 
mortality have been reported.
Owing to the wide spectrum of clinical presentations, 
diagnosis of TTS is often challenging. However, early rec-
ognition of this syndrome is key to adopting an appropriate 
therapy. Multimodality imaging is helpful in reinforcing the 
clinical suspicion of TTS in the early phase, allowing con-
firmation of the diagnosis, even retrospectively, after ruling 
out other clinical entities that should be considered in the 
differential diagnosis. The aim of this consensus document 
is to discuss and review the utility of multimodality imag-
ing, including left ventriculography, echocardiography, 
computed tomography (CT), magnetic resonance imaging, 
and nuclear imaging, in the diagnostic workup of TTS.
Diagnostic criteria
Several diagnostic criteria for TTS have been proposed, 
including those issued by the Mayo Clinic, the Japanese 
guidelines [12], the Tako-tsubo Italian Network, the Goth-
enburg group, and the Heart Failure Association (HFA) TTS 
Taskforce of the European Society of Cardiology (ESC). 
Recently, the InterTAK diagnostic criteria have also been 
developed [3] that incorporate several different aspects: (i) 
right ventricular (RV) involvement and other atypical wall 
motion abnormalities (WMAs); (ii) emotional or physical 
stress are no longer mandatory features; (iii) neurological 
disorders and pheochromocytoma are considered as potential 
triggers for TTS; and finally (iv) the possibility of coexist-
ing significant coronary artery disease and TTS has been 
confirmed (Table 2). According to the 4th universal crite-
ria of myocardial infarction, the diagnosis of TTS should 
be based on the absence of coronary artery disease, or, if 
present (about 15% of cases), it should not be sufficient to 
explain the observed pattern of regional WMAs. Addition-
ally, criteria for diagnosis of types 1, 2, and 4 myocardial 
infarction should be excluded [5].
Clinical course
Although initial studies suggested that prognosis of TTS 
is benign (in-hospital death 1–1.7%) [13, 14], recent data 
have shown higher in-hospital mortality rates (3.5–5%) [9, 
15, 16]. Clinical characteristics that were associated with 
in-hospital adverse events or death included male gender, the 
presence of physical triggers, acute neurologic or psychiatric 
disease, the first troponin level, and a LV ejection fraction 
(EF) of <45% [7]. Multiple unfavourable echocardiographic 
findings (described in the next sections) were associated 
with in-hospital complications, with evidence of RV involve-
ment being associated with poor long-term outcomes [15].
Cardiac catheterization: coronary 
angiography and left ventriculography
Coronary arteries are generally normal or near-normal in 
TTS. Although echocardiography is the first-line imaging 
modality in patients with suspicion of TTS, assessment of 
coronary anatomy is crucial in TTS diagnostic workup to 
rule out alternative diagnoses. As recommended by current 
guidelines on acute coronary syndromes (ACS), cardiac 
Table 1  InterTAK classification of takotsubo syndrome based on the 
type of triggering event (from Ghadri et al. [4])
Class I: takotsubo syndrome related to emotional stress
Class II: takotsubo syndrome related to physical stress
IIa: takotsubo syndrome secondary to physical activities, medical 
conditions, or procedures
IIb: takotsubo syndrome secondary to neurologic disorders
Class III: takotsubo syndrome without an identifiable triggering 
event
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catheterization should be performed in all patients with 
acute cardiac ischaemia and ST-segment elevation or in 
patients without ST-segment elevation according to the 
individual risk profile, especially for patients with a low-
intermediate probability of TTS [10, 17–21].
Coronary anatomy should be carefully evaluated using 
multiple angiographic views, ensuring that all lesions 
have been assessed in at least two orthogonal projections. 
Obstructive atherosclerotic plaques can be observed in about 
1 in 10 of TTS patients [3, 18]. It must be emphasized that 
obstructive single-vessel coronary lesions are not an abso-
lute exclusion criterion for diagnosis, since LV WMAs usu-
ally extend beyond a single epicardial vascular distribution 
in TTS, whilst equally non-obstructive plaques can cause 
myocardial infarction (Fig. 1) [10, 18, 19]. 
The diagnosis of TTS can also be established during 
cardiac catheterization through LV opacification. Biplane 
left ventriculography in the right and left anterior oblique 
projections allows for the assessment of nine LV segments 
and differentiation of TTS from anterior ST-elevation 
myocardial infarction (STEMI) in the majority of cases 
[19, 22]. The ‘apical nipple’ sign, a very small zone with 
preserved contractility of the LV apex, has been described 
on left ventriculography in about 30% of patients with 
TTS and typical apical ballooning (Fig. 2) [23]. This sign 
can be a useful additional tool to discriminate TTS from 
acute anterior STEMI, in which the phenomenon is not 
observed. Similarly, in patients with the mid-ventricular 
variant, systolic contraction of the apex can configure the 
hawk’s beak appearance by ventriculography (Fig. 3) [24, 
25]. In addition, the LV chamber silhouette depicted by 
the right anterior oblique view may show the typical apical 
ballooning or one of the variant morphologic patterns, 
which are suggestive of TTS diagnosis (Fig. 4) [7, 26]. 
Given the transient and reversible course of WMAs, left 
ventriculography should be performed in all patients with 
suspected TTS, especially if no transthoracic echocardio-
gram is available or in patients with poor acoustic window 
[8]. LV opacification may also be useful to identify pos-
sible mechanical complications such as acute mitral regur-
gitation (MR) or LV apical thrombi, which have prognostic 
implications [14]. Before removal, the catheter should be 
withdrawn slowly from the LV cavity in order to assess 
invasively intraventricular pressure gradients and possibly 
detect LV outflow tract obstruction (LVOTO), particularly 
in patients with haemodynamic instability [26].
Although not specific for TTS, coronary anatomical 
variants, including myocardial bridging or long and tortu-
ous arteries, are common findings on CA [27]. Likewise, a 
high thrombolysis in myocardial infarction frame count is 
frequently observed and has been associated with coronary 
microcirculation dysfunction with consequent slow coronary 
flow [28, 29]. Beyond the identification of significant coro-
nary lesions using conventional angiography, TTS diagnosis 
requires the exclusion of any other epicardial mechanisms 
potentially involved in other types of MINOCA such as 
plaque rupture or erosion and above all spontaneous coro-
nary artery dissection [30]. The use of intravascular imaging 
modalities, e.g., optical coherence tomography and intravas-
cular ultrasound, may help to clarify alternative aetiologies 
of myocardial injury [31, 32]. However, given the technical 
complexity and high costs, the application of these tools 
should be considered only in selected cases with unclear or 
inconclusive angiographic findings.
Table 2  InterTAK diagnostic criteria for takotsubo syndrome (from Ghadri et al. [3])
a Wall motion abnormalities may remain for a prolonged period of time or documentation of recovery may not be possible. For example, death 
before evidence of recovery is captured
b Cardiac magnetic resonance imaging is recommended to exclude infectious myocarditis and to confirm diagnosis of takotsubo syndrome
1. Patients show  transienta left ventricular dysfunction (hypokinesia, akinesia, or dyskinesia) presenting as apical ballooning or mid-ventric-
ular, basal, or focal wall motion abnormalities. Right ventricular involvement can be present. Besides these regional wall motion patterns, 
transitions between all types can exist. The regional wall motion abnormality usually extends beyond a single epicardial vascular distribu-
tion; however, rare cases can exist where the regional wall motion abnormality is present in the subtended myocardial territory of a single 
coronary artery (focal TTS)b
2. An emotional, physical, or combined trigger can precede the takotsubo syndrome event, but this is not obligatory
3. Neurologic disorders (e.g. subarachnoid haemorrhage, stroke/transient ischaemic attack, or seizures) as well as pheochromocytoma may 
serve as triggers for takotsubo syndrome
4. New ECG abnormalities are present (ST-segment elevation, ST-segment depression, T-wave inversion, and QTc prolongation); however, 
rare cases exist without any ECG changes
5. Levels of cardiac biomarkers (troponin and creatine kinase) are moderately elevated in most cases; significant elevation of brain natriuretic 
peptide is common
6. Significant coronary artery disease is not a contradiction in takotsubo syndrome
7. Patients have no evidence of infectious  myocarditisb
8. Post-menopausal women are predominantly affected
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Figure  1  Patient with takotsubo syndrome (TTS) and concomitant 
significant coronary artery disease. Caudal (a) and cranial (b) angio-
graphic views of the left coronary artery. Left cranial view (c) of the 
right coronary artery. Note the significant stenosis in the circumflex 
artery (arrow, a) and in the right coronary artery (arrow, c). Typical 
apical ballooning pattern of TTS at left ventriculography (d and e). 
(Reprinted with permission from Parodi et al. [18])
Figure 2  Left ventriculography of a patient with takotsubo syndrome and typical apical ballooning pattern. Note the presence of the ‘apical nip-
ple’ sign, a small area just at the apex with preserved contractility (arrow heads)
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Figure 3  Left ventriculography of a patient with takotsubo syndrome and midventricular ballooning pattern. Note the left ventricular apex in 
end-systole resembling hawk’s beak appearance (arrow heads)
Figure  4  Left ventriculography in the right anterior oblique projection demonstrates four different morphological patterns of takotsubo syn-
drome (TTS): apical, midventricular, basal, and focal type. (Modified and reprinted with permission from Templin et al. [7])
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Key points
• CA should be performed in ACS according to guide-
lines in all STEMI and intermediate to very high-risk 
non-STEMI presentations.
• Obstructive coronary stenosis does not represent an 
absolute exclusion criteria for TTS, but if coronary 
artery disease is present, it should not be sufficient to 
explain the observed regional WMAs.
• Biplane left ventriculography allows assessment of LV 
function and morphology in TTS.
• In selected cases, intravascular imaging and functional 
testing to rule out vasospasm may be helpful for the 
differential diagnosis.
the ‘midventricular’ form, akinesis is confined to the mid 
segments whereas the apical segments are normal or only 
mildly hypokinetic [8]. These two morphologic variants 
account for the vast majority of TTS and are both charac-
terized by myocardial dysfunction involving the opposite 
LV wall beyond the territory of a single coronary artery 
distribution [36]. This circumferential pattern of myocardial 
dysfunction represents a hallmark of TTS diagnosis [33] and 
should always be described in the echo report.
Other rare forms (i.e. basal or focal) are difficult to diag-
nose with certainty on echocardiography alone; in particular, 
the focal type is usually suspected only after exclusion of 
other possible aetiologies in the differential diagnosis.
RV involvement should be assessed in parasternal long-
axis, apical and subcostal four-chamber views, adjusting the 
echo transducer to the level of the RV chamber to achieve 
optimal visualization of its size and endocardial borders 
(Supplementary data online, Videos S3). RV involvement 
[37] is usually identified by the detection of severe akinesis 
or dyskinesis, localized exclusively at the apical and/or mid 
RV segments (biventricular ballooning) [38], with sparing of 
the basal segments (‘reverse McConnell’s sign’) [39].
Biventricular ballooning reinforces the diagnostic suspi-
cion of TTS, especially if pulmonary hypertension and acute 
pulmonary embolism are excluded. RV involvement has 
Table 3  Main 
echocardiographic findings in 
takotsubo syndrome
EF, ejection fraction; LV, left ventricular; RV, right ventricular; TTS, takotsubo syndrome; WMAs, wall 
motion abnormalities.
LV systolic function Marked reduction in LVEF on admission with improvement at short term
LV WMAs •Independent of the distribution of epicardial coronary artery (circum-
ferential pattern)
•Apical ballooning
•Variant form: mid-ventricular ballooning; inverted TTS
RV involvement Reverse McConnell sign (biventricular ballooning)
Speckle-tracking Circumferential impairment of LV longitudinal and radial strain
Coronary flow •Preserved distally to the coronary artery
•Coronary flow reserve is impaired in the acute phase
Table 4  Echocardiographic findings of high risk in takotsubo syndrome
CO, cardiac output; EF, ejection fraction; LV, left ventricular; 
LVOTO, left ventricular outflow tract obstruction; MR, mitral regur-









Left ventricular wall rupture
Role of standard echocardiography
Transthoracic echocardiography (TTE) is the first-line 
imaging modality for the evaluation of patients with TTS 
[33]. If suspicion of TTS arises, echocardiography should 
be promptly performed because it provides useful informa-
tion about systolic and diastolic function, RV involvement, 
haemodynamic status, mechanical complications, pulmo-
nary artery systolic pressure, pericardial effusion, and LV 
intraventricular thrombi [26]. Echocardiographic findings 
are also helpful to identify patients at higher risk of adverse 
outcome and to monitor regression of WMAs (Tables 3 and 
4).
Wall motion abnormalities and morphologic 
anatomical variants
Firstly, TTE may help to detect the distribution of WMAs 
and determine the morphologic anatomical variant [8, 34].
In the ‘apical ballooning’ form, the apex and/or mid-
ventricular myocardial segments are diffusely akinetic 
while basal segments are hyperkinetic (Supplementary 
data online, Videos S1 and S2) [8, 33–35]. Conversely, in 
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been associated with adverse in-hospital outcomes [14, 40]. 
It should be taken into account that in some cases of ante-
rior myocardial infarction with wrap-around morphology of 
the left anterior descending artery (LAD), RV involvement 
beside LV apical akinesia can be appreciated [41].
Systolic and diastolic function
Systolic function should be carefully defined since a marked 
reduction in LVEF on admission is associated with adverse 
in-hospital outcomes, particularly in elderly patients and 
in those with physical stressors [42, 43]. Recent data also 
suggest that advanced systolic dysfunction could negatively 
affect outcomes even after hospital discharge [44].
Spontaneous myocardial function recovery, typically 
associated with TTS, should ideally be monitored with daily 
echocardiography during the acute phase [45].
Additionally, echocardiographic diastolic indices, namely 
the E/e′ ratio, should be assessed early and systematically 
to identify patients at higher risk for acute heart failure and 
to guide appropriate management. Given that diastolic dys-
function is also transient and reversible, improvements in 
the E/e′ ratio can be used as an additional marker of LV 
functional recovery [8, 14].
Mechanical complications (left ventricular 
outflow tract obstruction and reversible mitral 
regurgitation)
Echocardiography in the acute phase allows the prompt 
identification or exclusion of several important mechanical 
complications, including LVOTO, MR, and myocardial wall 
rupture [46–48].
Dynamic LVOTO, defined as an intraventricular gradi-
ent >25 mmHg, results from basal hypercontractility in 
the small LV cavity with asymmetric hypertrophy of the 
interventricular septum [49]. Its prevalence ranges from 
12.8% to 25% [50]. The degree of LVOTO is variable and 
reversible depending on loading conditions and myocar-
dial function recovery. It may be associated with systolic 
anterior motion of the mitral valve (SAM), leading in turn 
to MR (Supplementary data online, Videos S4–S6; Fig. 5) 
[51, 52]. Since concomitant LVOTO and MR further con-
tribute to haemodynamic instability, early echocardio-
graphic identification has important therapeutic implica-
tions. In this clinical scenario, administration of inotropic 
agents and diuretics results in enhanced basal contractility 
and volume depletion, respectively. These both increase 
intraventricular pressure gradients with worsening of the 
haemodynamic status, ultimately leading to acute heart 
failure and cardiogenic shock [53]. It is therefore recom-
mended to discontinue inotropic agents and administer flu-
ids while monitoring the patient’s haemodynamic status. 
If TTE confirms the persistence of SAM with low cardiac 
output, current recommendations suggest the use of LV 
assist devices to improve cardiac output [3, 10, 17, 54]. 
Beyond SAM related to LVOTO, another possible 
cause of transient and reversible MR is leaflet tethering 
secondary to papillary muscle displacement in a dilated 
left ventricle with severely impaired LV systolic function 
(Fig. 6) [55, 56]. Transient moderate to severe MR has 
been reported in about 20–25% of TTS patients and is 
associated with advanced Killip class [14, 51]. Also, pul-
monary artery systolic pressure should be assessed by TTE 
at every follow-up (FU) exam, particularly in TTS patients 
with signs or symptoms of heart failure.
Figure  5  Two-dimensional transthoracic echocardiography, apical 
long-axis views, in patients with mitral regurgitation (MR) due to 
systolic anterior motion (SAM) of the mitral valve. (A) Severe MR 
at initial presentation. (B) SAM of the mitral valve at initial presen-
tation. (C) Only mild MR was found at follow-up. (D) SAM of the 
mitral valve was not found at follow-up. (Modified from Izumo et al. 
[55])
Figure  6  Two-dimensional transthoracic echocardiography, apical 
four-chamber views, in patients with functional mitral regurgitation 
(MR). (A) Moderate to severe MR at initial presentation. (B) Mitral 
valve tethering at initial presentation. (C) Only mild MR was found 
at follow-up. (D) Mitral valve tethering was not found at follow-up. 
(Modified from Izumo et al. [55])
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Intraventricular thrombi
Extensive apical myocardial dysfunction and reduced 
intraventricular systolic flow velocity are predisposing 
factors for thrombus formation. In patients with TTS, 
mural or pedunculated thrombi visualized at the apex dur-
ing the first 2 days have an incidence of 1–2% and may 
cause stroke or systemic embolization (renal or lower 
limb embolism) in approximately one-third of cases [57]. 
After thrombus detection, therapy with heparin followed 
by oral anticoagulation should be instituted, and serial 
TTE should be performed until thrombus resolution and 
myocardial contractility recovery [8]. Use of real-time 3D 
echocardiography or contrast agents may also be helpful 
in detecting small thrombi [8, 58].
Left ventricular wall rupture
LV free wall or interventricular septum rupture is a very 
rare (<1%) life-threatening complication burdened by high 
mortality rates due to cardiogenic shock and/or cardiac tam-
ponade. In the presence of clear haemodynamic instability, 
prompt echocardiographic detection of this complication is 
important to favour rapid referral for surgery [59, 60].
Pericardial effusion
Pericardial effusion is rarely described in TTS [61, 62] and 
is more frequently associated with an inflammatory disease 
of the myocardium and/or pericardium. If pericardial effu-
sion is detected, further investigation by cardiac magnetic 
resonance (CMR) should be performed to investigate the 
differential diagnosis of myocarditis [17, 26].
Strain imaging by speckle tracking 
echocardiography
Strain imaging by speckle tracking echocardiography allows 
assessment of global and regional myocardial function in 
all three layers of myocardium, and which can be applied 
to assess strain in the longitudinal, circumferential, and 
radial directions. Owing to the ability of strain imaging to 
objectively depict the transient impairment of myocardial 
deformation with circular involvement of the opposite LV 
walls (circumferential pattern), speckle tracking assessment 
in TTS patients should be performed, whenever possible, 
even in the acute phase. Furthermore, it is a useful tool to 
monitor myocardial functional recovery [63–73] (Fig. 7). LV 
twist is also transiently impaired in the acute phase of typi-
cal TTS, mainly due to apical dysfunction, with secondary 
alterations in the normal rotational pattern of contraction 
[74]  (Fig. 8). LV early untwisting rate, an index of diastolic 
function, is also decreased in the acute phase. Recent stud-
ies have further demonstrated RV involvement in TTS as an 
important finding associated with worse outcome [75–80]. 
Traditional echocardiographic parameters used to assess RV 
function, such as RV fractional area change and tricuspid 
annular plane systolic excursion, do not account for contrac-
tion abnormalities of the mid- or apical RV segments and 
are instead predominantly affected by basal hyperkinesis. 
RV free wall longitudinal strain is therefore recommended 
in order to detect even small areas of myocardial dysfunction 
hardly recognizable by visual assessment and/or by other 
traditional echocardiographic parameters. Conversely, RV 
global longitudinal strain should not be assessed because 
involvement of the interventricular septum can be mislead-
ing [81].
WMAs and LVEF usually recover to normal within a few 
weeks. However, several studies have shown that significant 
mechano-temporal alterations affecting both systole (global 
longitudinal strain and apical circumferential strain) and 
diastole (untwist rate and time to peak untwisting), reduced 
exercise capacity, increased native T1 mapping values and 
impaired cardiac energetics can persist for months after the 
acute phase, despite normalization of LVEF and volumes 
[67, 82].
The long-term prognosis of patients who experienced 
TTS seems to be worse than that in the general population; 
the underlying mechanism may be partly due to persistence 
of oedema/inflammation, with residual functional abnor-
malities observed on strain imaging [16, 46, 68, 74].
Together with other clinical, functional, and metabolic 
testing, these studies provide evidence that structural and 
functional myocardial abnormalities often persist after TTS. 
These findings do not rule out the diagnosis of TTS and 
emphasize the need for systematic follow-up. At 1 month 
Key points
• Echocardiography is the first-line imaging modality 
in patients with suspected TTS.
• In diagnostic workup, echocardiography is useful to 
recognize the apical-midventricular ballooning and 
circumferential patterns of WMA distribution.
• Echocardiography is useful to monitor the recovery of 
systolic function and to detect the occurrence of com-
plications (i.e. LVOTO, reversible moderate to severe 
MR, RV involvement, LV thrombi, and pericardial 
effusion).
• RV involvement reinforces the diagnostic suspicion of 
TTS and has been associated with adverse in-hospital 
outcome.
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from TTS onset, a clinical and echocardiographic fol-
low-up is mandatory: in case of persisting WMAs, ECG 
changes, elevated levels of B-type natriuretic peptide and/
or symptoms, a second follow-up visit should be scheduled 
at 3 months, conversely the patient should be evaluated at 
6 months and 1 year, and then annually. Careful evaluation 
of persistent systolic and diastolic alterations using speckle 
tracking echocardiography could add important prognostic 
information and aid clinical decision-making.
Transthoracic coronary Doppler
Visualization of coronary flow in the distal part of the LAD 
by transthoracic Doppler can help to differentiate TTS from 
acute myocardial infarction (AMI) due to LAD occlusion 
(Fig. 9) [9, 83–85] and also provides non-invasive physi-
ological information on coronary blood flow. Through the 
ratio of hyperaemic to baseline diastolic peak flow velocity 
in the distal LAD, this method also allows the assessment 
Figure 7  Longitudinal strain in a patient with typical type of takot-
subo syndrome demonstrating left ventricular strain acquisition from 
standard apical view. Apical ballooning and a base to apex circular 
gradient of strain are appreciated by the bull’s eye plot, which recov-
ers to normal at follow-up
Figure 8  Impaired left ventricular (LV) twist by speckle tracking. In the acute phase, LV twist is significantly impaired mainly due to impaired 
apical function
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of coronary flow reserve after administration of coronary 
vasodilator agents (e.g. as adenosine or dipyridamole) [86]. 
In the acute phase of TTS, coronary flow reserve is reduced 
due to transient coronary microcirculation impairment and 
recovers prior to LV wall motion normalization [85, 87–90]. 
The decrease in coronary flow reserve in TTS seems to be 
milder than that in AMI, although TTS has worse WMAs 
than AMI, suggesting that microvascular dysfunction is not 
the only mechanism of TTS [91].
In daily practice, this tool is of limited value, although it 
may be useful for monitoring the recovery of coronary flow 
reserve in doubtful cases.
Contrast echocardiography
In clinical practice, the most important application of con-
trast echocardiography is LV cavity opacification for the 
detection of WMAs [92] (Fig. 10) and the determination of 
the morphologic pattern of TTS in patients with poor acous-
tic window. Furthermore, the use of ultrasound contrast 
agents improves the detection of intraventricular thrombi, 
directing prompt introduction of anticoagulant therapy [9]. 
Finally, contrast echocardiography may be used to improve 
visualization of coronary flow by TTE with colour and 
pulsed wave Doppler [83, 85,86].
Of note, myocardial contrast echocardiography performed 
within 24 h after TTS onset revealed reversible perfusion 
defects in involved segments, which improved faster than 
WMAs [91].
Figure 9  Visualization of coronary flow in acute myocardial infarc-
tion (AMI) and takotsubo syndrome (TTS). Cases 1–3 indicate 
coronary flow pattern in AMI. Systolic-dominant flow pattern with 
reduced diastolic flow velocity in Case 1, to-and-from pattern in Case 
2, and absence of coronary flow in Case 3, all indicate severe steno-
sis/occlusion of the left anterior descending artery (LAD). In Case 
4, antegrade diastolic coronary flow with reduced deceleration time, 
typical of TTS in the acute phase. LA, left atrium; LV, left ventricle. 
(Modified and reprinted with permission from Watanabe [84])
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3D echocardiography
3D echocardiography is a useful method to quantify cham-
ber measurements with higher accuracy and reproducibility 
than 2D echocardiography [93] (Figs. 11 and 12). 3D visu-
alization may enable more objective assessment of regional 
WMAs and EF, especially in the right ventricle because of 
its complex morphology [94]. As 2D echocardiography has 
a limited ability to detect RV involvement [79], 3D echo-
cardiography might help identify RV involvement [95] and 
improve risk stratification in patients with TTS. However, 
there is a paucity of data and further studies are warranted.
These ‘advanced’ echocardiography techniques, includ-
ing strain imaging, coronary flow assessment, contrast echo-
cardiography, and 3D echocardiography, are emerging and 
hold promise in improving our understanding of the patho-
physiology underlying TTS. However, it should be acknowl-
edged that the clinical utility of these techniques has not 
been fully established and physicians should not make clini-
cal decisions solely on this basis.
Figure  10  Opacification of wall motion abnormalities by contrast 
echocardiography. Left and right panels show apical four-chamber 
views with and without contrast agent in a case of takotsubo syn-
drome. Contrast echocardiography helps opacification of wall motion 
abnormalities, especially in patients with poor echo images. LA, left 
atrium; LV, left ventricle; RV, right ventricle
Figure  11  Simultaneous three-dimensional modelling of cardiac 
chambers. Latest echo machines enable automated 3D quantification 
of chamber volumes and ejection fractions of the four cardiac cham-
bers. 3D quantification has been reported to have higher accuracy 
and reproducibility than two-dimensional echocardiography. LA, left 
atrium; LV, left ventricle; RA, right atrium; RV, right ventricle
Figure 12  3D assessment of wall motion abnormality. In addition to 
quantification of volumes, 3D echocardiography is useful for visual 
confirmation of patterns of wall motion abnormality. The left and 
right panels indicate an end-diastolic and end-systolic phase, which 
clearly depicts apical ballooning with basal hyperkinetic motion
Key points
• LV mechanics are profoundly and transiently impaired 
in TTS, in a pattern that differs from AMI.
• Whilst EF and WMAs resolve in TTS, some subtle 
wall strain abnormalities can persist.
• The coronary microcirculation is transiently compro-
mised in TTS, but its physiological role is still unclear.
• Contrast echocardiography should be used in patients 
with poor acoustic window to better define WMAs 
and the presence of intraventricular thrombus.
• Compared to 2D echocardiography, 3D echocardiog-
raphy enables more accurate assessment of regional 
WMAs and may be a useful tool to better detect and 
assess RV involvement, even in the acute care setting.
• As an additional prognostic tool, RV strain could be 
useful in assessing the extent of RV involvement.
Cardiac magnetic resonance
Although echocardiography and left ventriculography have 
mainly been used to diagnose LV WMAs in patients with 
TTS, CMR plays an important role in the comprehensive 
assessment of the functional and structural changes that 
occur in patients with clinical suspicion of TTS [96]. CMR 
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represents the reference standard for qualitative and quan-
titative assessment of regional WMAs and accurate quanti-
fication of right and LV volumes and function. Other addi-
tional abnormalities, including pericardial effusion, pleural 
effusion, and intraventricular thrombi, can also be easily 
appreciated. However, the major strength of this imaging 
technique is myocardial tissue characterization, due to its 
unique ability to provide different markers of myocardial 
injury. The detection of oedema/inflammation rather than 
fibrosis or necrosis is useful to distinguish reversible from 
irreversible myocardial damage and is helpful in guiding the 
differential diagnosis between TTS, other MINOCA presen-
tations and ACS.
Ventricular morphology and function
Balanced steady-state free precession (bSSFP) including 
short-axis plane covering the entire left ventricle and three 
long-axis planes (two-chamber, four-chamber, and LVOT 
view), should be systematically performed during CMR 
(Supplementary data online, Videos S7–S10). These planes 
enable precise visualization of the contractile dysfunc-
tion pattern (Fig. 13) and have an additive role in better 
defining basal ballooning or focal forms, where limited 
WMAs can be missed at echocardiography. In addition to 
a high-resolution illustration of regional LV dysfunction/
ballooning, bSSFP images of double oblique short-axis 
or four-chamber views also enable accurate assessment 
of RV WMAs. The detection of RV involvement has been 
associated with prolonged hospital stay and higher rates 
of short- and long-term adverse events [15, 75–77, 80]. 
Conversely, due to the complex geometry of the right 
ventricle, detailed estimation of RV function using TTE 
can be challenging.
It is also noteworthy that CMR can visualize thrombi in 
the LV apex, which may cause subsequent systemic embo-
lism, and can detect other complications as well (e.g. peri-
cardial effusion, LVOTO) [96, 97].
Recently, CMR-feature tracking (FT) has been intro-
duced as a new method to quantify regional LV defor-
mation similarly to speckle tracking echocardiography, 
providing a more reliable and accurate assessment of 
(dys-)synchrony as well as rotational parameters [98]. 
In TTS patients, CMR-FT of the left and right ventricles 
has shown promising results [66, 99]. Transient circum-
ferential dyssynchrony and impaired rotational mechan-
ics are distinct features of TTS with varying degree of 
severity according to the ballooning pattern. Moreover, 
the assessment of RV myocardial strain using CMR-FT 
enables accurate evaluation of RV involvement in TTS and 
represents a promising approach for optimized risk stratifi-
cation (Fig. 14). However, the clinical value of these novel 
parameters for the identification of high-risk patients, as 
well as the already described transient impairment of left 
atrial performance, needs to be validated in future pro-
spective studies [100].
Myocardial tissue characterization
CMR has the advantage of enabling multiparametric myo-
cardial tissue characterization. Specifically, CMR can rule 
out ischaemic myocardial injury or myocarditis using late 
gadolinium-enhancement (LGE) imaging (Fig. 15) [96]. 
While LGE in myocarditis reveals patchy myocardial 
Figure 13  Cine cardiac magnetic resonance of a takotsubo syndrome (TTS) patient. A two- and four-chamber view of the left ventricle in a rep-
resentative TTS patient with apical ballooning
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necrosis and fibrosis (rarely subepicardial or transmural), the 
absence of LGE is a quite common finding in patients with 
TTS and is considered as a diagnostic criterion [101, 102]. 
However, several studies have reported that, when using 
LGE signal intensity (SI) threshold of 3 standard deviations 
(SD), subtle focal or patchy LGE can be detected also in 
patients with TTS [96, 103–105] Noteworthy, if SI threshold 
of 5 SDs above the mean remote myocardium is used, no 
areas of LGE are detectable in TTS patients [96].
Although patchy areas of LGE can be detected in TTS 
patients using low SI thresholds, the transient nature of this 
myocardial injury, which generally disappears within few 
days or weeks, as well as the absence of LGE at high SI 
thresholds are distinctive patterns that differentiate TTS 
from AMI and myocarditis. It has been suggested that an 
increase of extracellular matrix rich in collagen-1, as a find-
ing of transient fibrosis, might be accountable for the LGE 
observed in TTS [106].
In conclusion, these evidences suggest that the absence 
of LGE at high SI thresholds is still a diagnostic criterion 
for TTS, keeping in mind that small amounts of reversible 
patchy areas of LGE can be transiently detected using low 
SI thresholds and do not represent an absolute exclusion 
criterion during diagnostic work-up.
The impact of LGE on clinical outcomes in TTS remains 
controversial. Although some authors have reported worse 
clinical prognosis in patients with LGE, no differences in clin-
ical outcomes between patients with and without LGE have 
been found in a multicentre prospective registry [96, 103].
T1 mapping techniques, where T1 time of injured myo-
cardium is quantitatively and more objectively assessed, can 
be useful to detect very subtle areas of damage in patients 
with TTS (Fig. 16). Assessment by T1 mapping may provide 
better understanding of TTS pathophysiology, and the first 
Figure 14  Analysis of right ventricular (RV) longitudinal strain. Cardiac magnetic resonance-feature tracking of long-axis four-chamber views to 
quantify longitudinal RV strain in a takotsubo syndrome patient with and without RV involvement
Figure  15  Different late gadolinium enhancement (LGE) patterns 
in myocardial infarction with non-obstructive coronary arteries 
(MINOCA). (a and b) Myocardial infarction with spontaneous lysis 
of thrombus with subendocardial ischaemic LGE of the lateral wall in 
two-chamber (a) and three-chamber view (b). (c) Patchy, subepicar-
dial non-ischaemic LGE in a patient with myocarditis (four-chamber 
view). (d) Absence of irreversible tissue injury (LGE) when signal 
intensity threshold of 5 standard deviation is used in a patient with 
takotsubo syndrome (four-chamber view)
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published data have revealed that native T1 values in TTS 
are significantly higher than in control subjects, suggest-
ing that these new mapping techniques can better identify 
reversible and irreversible myocardial injury [82].
Up to date, cut-off values of native T1 mapping have not 
been established in this setting. This technique is still con-
sidered a research tool and its impact on clinical practice and 
outcome needs to be further investigated.
Myocardial oedema is another distinctive feature of TTS. 
The exact pathophysiological mechanisms underlying the 
development of myocardial oedema in TTS is still unclear. 
Increased LV wall stress and/or transient ischaemia seem to 
be responsible for inflammatory injury of cell membrane, with 
subsequent transmembranous leakage of water and large mol-
ecules leading to extracellular oedema. It can be detected by 
T2 weighted black blood imaging (T2BB) or newer mapping 
techniques (i.e. native T1 mapping and T2 mapping). T2BB 
allows to recognize oedema due to the suppression of both 
fat and flowing blood signal. In T2BB imaging, a triple inver-
sion recovery fast-spin echo sequence is used in contiguous 
short-axis views of the left ventricle. A ratio of mean SI of the 
myocardium compared with that of the skeletal muscle (T2 SI 
ratio) ≥1.9 is generally accepted to define oedema. Myocar-
dial oedema is generally localized in segments with abnormal 
contraction (a-hypokinesis) showing a diffuse or transmural 
distribution. Its acute extent also correlates with acute release 
of both catecholamines and N-terminal pro-B-type natriuretic 
peptide [82]. It is a transient and reversible phenomenon, 
typically detectable during the acute phase, which gradually 
disappears within few weeks along with the recovery of myo-
cardial contractility. Oedema is a key diagnostic feature for 
assessing in vivo the acuity, extent, and severity of myocardial 
stunning in TTS [108] (Fig. 17).
When to perform CMR in TTS
In the acute phase, CMR should be used, whenever possible, 
when echocardiographic images are suboptimal, given its 
ability to provide more detailed information about ventricular 
morphology and function, RV involvement, intraventricular 
thrombi, and pericardial effusion. Moreover, in case of an 
ambiguous clinical picture, CMR is recommended to detect 
the presence of oedema, a hallmark finding of TTS, and to rule 
out other forms of MINOCA in order to adopt the appropriate 
therapeutic strategy. Being myocardial stunning in TTS tran-
sient and reversible, complete, or near complete recovery is 
expected and necessary to retrospectively confirm TTS diagno-
sis. In the post-acute phase, CMR is mandatory within 1 month 
of TTS onset in all patients without an identifiable trigger event 
(Class III TTS). Additionally, CMR is recommended in case of 
incomplete recovery (persisting ECG changes and/or WMAs at 
echocardiography) and atypical presentation (Class II TTS sec-
ondary to other illness, e.g. sepsis, pancreatitis, cholecystitis, 
bone fracture, asthma crisis, cardiac and non-cardiac surgery, 
and anaesthesia) to assess tissue characterization and defini-
tively corroborate TTS diagnosis.
Key points
• CMR can visualize the entire spectrum of functional 
and structural changes that occur in patients with TTS.
• CMR diagnostic criteria for TTS include the combina-
tion of:
– typical regional WMAs (apical, mid-ventricular, or 
basal ballooning);
– presence of reversible tissue injury (oedema);
– absence of irreversible tissue injury (LGE) when SI 
thresholds of 5 standard deviations are used.
• CMR provides additional value to other imaging 
modalities for differential diagnosis (myocardial 
infarction, myocarditis), pathophysiological insights, 
and detection of complications (e.g. LV thrombi) in 
TTS.
• In the acute phase, CMR is recommended in doubt-
ful TTS cases, especially if diagnosis of another type 
of MINOCA (e.g. myocarditis) requires a different 
therapeutic approach.
• In the post-acute phase, CMR is mandatory in all 
patients within 2 months, especially in case of per-
sisting ECG abnormalities and/or regional WMAs 
at echocardiography, in order to definitively confirm 
the diagnosis of TTS.
Coronary computed tomography 
angiography
Technological developments over recent years have empha-
sized the role of coronary computed tomography angiog-
raphy (CCTA) in the evaluation of patients with suspected 
TTS [109–111].
An advantage of both CCTA and CMR is the ability to 
evaluate the heart in any potential plane, overcoming the 
limitations imposed by suboptimal acoustic windows on 
echocardiography [112]. Moreover, unlike CA, this imaging 
modality is not invasive and, compared with CMR, can be 
readily used in the emergency setting due to its accessibility 
and fast acquisition time. The main indication for CCTA in 
TTS patients relates to the assessment of the epicardial coro-
nary arteries and the ruling out of coronary artery disease, 
according to local expertise and availability [113].
CCTA has been proposed as a non-invasive alternative 
to CA in stable and pain-free patients with no ST-segment 
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elevation at onset and convincing clinical (post-men-
opausal woman, trigger event) and echocardiographic 
(apical ballooning, circumferential pattern, distal LAD 
flow visualization) findings consistent with TTS. This 
approach could be advantageous, particularly in patients 
with delayed presentation (>48 h after chest pain onset) or 
when CA is not available on site [8, 17].
Cardiac CT, beyond coronary artery disease, allows 
assessment of LV function and WMAs. Nowadays, car-
diac CT also provides myocardial characterization with 
late iodine enhancement imaging comparable with that 
obtained from CMR [114].
Owing to multiplanar imaging [115,  116] that over-
comes the limitations of echocardiography, multidetector 
CT permits a better identification of LV apical thrombi, 
a not so rare complication of TTS. Cardiac CT plays an 
important role in the diagnostic workup of patients with 
acute chest pain and doubtful TTS diagnosis to exclude 
other conditions such as pulmonary embolism and aortic 
dissection [117, 118]. Recently, a comprehensive assess-
ment of the coronary arteries, LV function, and myocardial 
late iodine enhancement has been performed in patients 
with suspected TTS [119], thus pointing to the growing 
importance of CCTA.
Figure 16  T1 mapping in 
takotsubo syndrome. End-
diastolic (a) and end-systolic 
(b) balanced steady-state free 
precession cardiac magnetic 
resonance images in horizontal 
long-axis view showing basal 
and mid-ventricular hypoki-
nesis and apical hyperkinesis 
compatible with reversed/basal 
takotsubo syndrome. Horizontal 
long-axis views of T2-weighted 
short tau inversion recovery (c) 
and late gadolinium enhance-
ment (e) images revealed subtle 
hyperintensity and patchy con-
trast enhancement in the basal 
and mid-ventricular segments of 
the left ventricle. Colour-coded 
native (d) and post-contrast 
(f) T1 maps using shortened 
modified Look-Locker inversion 
recovery (ShMOLLI) confirmed 
regional myocardial involve-
ment
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Up to date there is no evidence for delaying invasive CA 
in patients with ongoing acute chest pain and acute ECG 
changes. In such a clinical scenario, patients should be man-
aged according to current guidelines for STEMI or ACS 
until culprit coronary artery disease has been ruled out [20, 
21].
CCTA may be chosen instead of CA:
(1) in stable patients with low suspicion of ACS;
(2) in patients with suspected TTS recurrence;
(3) in other conditions generally associated with TTS such 
as critical illnesses (particularly sepsis, subarachnoid 
haemorrhage, or ischaemic stroke).
Moreover, CCTA can be considered as a non-invasive 
valuable alternative in life-threatening conditions where CA 
is highly likely to cause complications (e.g. terminal malig-
nancy and advanced age with frailty).
• CCTA may be chosen instead of CA in some peculiar 
situations:
• Stable patients with low suspicion of ACS;
• Patients with a history of TTS and suspected recur-
rence;
• Critical clinical conditions usually associated with 
TTS (e.g. sepsis, subarachnoid haemorrhage, or 
ischaemic stroke) or where CA is highly likely to 
cause complications (e.g. terminal malignancy and 
advanced age with frailty).
Figure 17  Myocardial oedema 
in takotsubo syndrome (TTS). 
TTS patient with typical apical 
ballooning displayed in end-
diastolic (a) and end-systolic 
(b) bSSFP imaging in horizon-
tal long-axis view. T2-weighted 
imaging (short tau inversion 
recovery) demonstrates circum-
ferential myocardial oedema in 
the left ventricular apical (c) 
and mid-ventricular (d) seg-
ments without involvement of 
the basal segments (e). bSSFP, 
balanced steady-state free 
precession
Key points
• The main indication for CCTA in TTS patients relates 
to the assessment of the epicardial coronary arteries 
and the ruling out of coronary artery disease.
• Cardiac CT also plays an important role in the diag-
nostic workup of patients with acute chest pain and 
doubtful TTS diagnosis to exclude other conditions 
such as pulmonary embolism and aortic dissection.
Nuclear imaging: single‑photon emission 
computed tomography and positron 
emission tomography
Although the role of nuclear imaging in TTS has not yet 
been well established in clinical practice, nuclear imaging 
can provide assessments of myocardial perfusion and meta-
bolic activity, improving our understanding of the patho-
physiology of TTS and potentially aiding diagnosis.
Some studies have reported that fatty acid metabolism 
depicted by 123I-beta-methy-iodophenyl pentadecanoic acid 
(123I-BMIPP) single-photon emission computed tomogra-
phy (SPECT) was more severely impaired than myocardial 
perfusion depicted by 201thallium scintigraphy in acute TTS 
patients [28, 120]. Reductions in perfusion tracer counts 
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occur as a result of regional myocardial wall thinning at the 
apex, due to both artefacts and partial volume effects, and 
may mimic ACS. Combined perfusion and metabolic imag-
ing can help identify this phenomenon and aid the diagnosis 
of TTS (Fig. 18).
123I metaiodobenzyl guanidine (MIBG) scintigraphy can 
assess myocardial sympathetic nerve terminal activity and 
detect adrenal and ectopic pheochromocytoma. Even in the 
subacute phase, the adrenergic hyperactivity observed in 
TTS results in decreased uptake and increased washout of 
123I-MIBG from the heart (Fig. 19) [26, 121]. Indeed, myo-
cardial 123I-MIBG uptake is impaired for months as a con-
sequence of regional disturbances in sympathetic neuronal 
activity [122]. The combination of 123I-MIBG and myocar-
dial perfusion scintigraphy is also useful for distinguishing 
TTS from ACS when innervation and myocardial scarring 
are matched.
Cardiac positron emission tomography (PET) using 
 [18F]2-fluoro-deoxy-glucose (FDG) shows abnormal glu-
cose metabolism alongside normal myocardial perfusion in 
TTS. Recently, some studies have been conducted at differ-
ent phases during the TTS time course [123, 124]. In the 
acute and subacute phases, similar defects of MIBG and FDG 
uptake were found, despite slightly reduced perfusion in TTS. 
Although rapid normalization of myocardial perfusion was 
observed, TTS patients had delayed recovery of both LV glu-
cose metabolism and sympathetic innervation. In the con-
text of normalized LV wall motion, the delayed recovery of 
glucose metabolism and sympathetic innervation may allow 
diagnosis in patients with delayed presentation, even within 
a few months of the suspected triggering episode.
The pathophysiology of TTS remains challenging and 
controversial. Several hypotheses have been proposed to 
explain this unique cardiac disorder [52, 125–128], which 
can be broadly categorized as vascular or myocardial causes. 
Temporal evolution of MIBG and FDG abnormalities has 
provided new insight into functional myocardial changes and 
their time course in TTS; however, the mechanisms of TTS 
remain undetermined. The diagnostic criteria of TTS have 
been updated, such that coronary artery disease and pheo-
chromocytoma are included in the new criteria. Therefore, 
nuclear imaging seems to be an ever more important imag-
ing modality for the assessment of TTS, not only for diag-
nostic purposes, but also as a research tool that can allow 
better understanding of the pathophysiology of TTS.
• In the context of normalized LV wall motion, the 
delayed recovery of glucose metabolism (by FDG-
PET) and sympathetic innervation (by 123I-MIBG 
scintigraphy) may allow diagnosis of TTS in patients 
with delayed presentation, even within a few months 
of the suspected triggering episode.
Key points
• Although the role of nuclear imaging in TTS has not 
yet been well established in clinical practice, myocar-
dial perfusion and sympathetic nerve innervation can 
be assessed by SPECT and MIBG.
Why and how to recognize TTS in COVID‑19 
era
Coronavirus disease 2019 (COVID-19) is a tremendous 
infectious disease firstly recognized in Wuhan, Hubei, China, 
that has spread throughout to other provinces in China and 
impetuously involved worldwide many countries causing a 
pandemic and a public health crisis of global proportions 
in 2020. Cardiovascular involvement, including acute coro-
nary syndromes, myopericarditis, and pulmonary embolism, 
has been associated to the clinical course of a substantial 
proportion of patients affected by severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2). Myocardial injury 
emerged as an important predictor of worst outcome. Shi 
et al. report a prevalence of 19.7% of cardiac injury, defined 
by high blood levels of high-sensitivity troponin I, among 
416 patients with confirmed diagnosis of SARS-CoV-2 
[129]. In this study, cardiac injury was associated with 
higher risk of in-hospital mortality. Their results are consist-
ent with another study by Guo et al. on 187 Chinese patients, 
which highlighted the association between myocardial injury 
and fatal outcome in SARS-CoV-2 patients [130].
As with other coronaviruses, an intense systemic inflam-
matory response secondary to SARS-CoV-2 may produce 
demand ischaemia and/or possible coronary plaque disrup-
tion. Moreover, the detection of increased levels of multiple 
cytokines and chemokines in patients hospitalized in inten-
sive care unit, suggests a direct myocardial damage as an 
alternative potential mechanism [131].
Noteworthy septic status, hypoxaemia, and metabolic 
acidosis; complications often detected in SARS-CoV-2 
patients, are established triggers for secondary TTS.
Owing to the detection of myocardial inflammatory 
infiltrates documented in TTS patients, possible shared 
pathophysiological pathways in occurrence of myocardial 
dysfunction might be hypothesized in patients with SARS-
CoV2 experiencing myocardial injury [82]. TTS and its pos-
sible complications such as acute heart failure, cardiogenic 
shock and life-threatening arrhythmias should be taken into 
consideration in differential diagnosis among various cardio-
vascular presentations associated with SARS-CoV-2 [132].
Imaging diagnostic tests are not routinely used in the 
emergency context of pandemic disease, the European 
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Association of Cardiovascular Imaging recommend per-
forming echocardiography at least in patients with labora-
tory or electrocardiographic signs of cardiac injury [133]. 
The suspect of TTS should arise in patients with echocar-
diographic evidence of extensive myocardial dysfunction 
especially if typical apical ballooning pattern is detected 
[134]. Clinicians should consider combining coronary CT 
with lung scanning (usually used for pneumonia disease) 
to exclude coronary artery disease. Multislice computed 
tomography (MSCT), being able to detect late iodine 
enhancement and myocardial fibrosis, is an additional 
tool to exclude myocarditis in this clinical context. Com-
pared with MSCT, CMR is able to recognize myocardial 
oedema, a hallmark sign of TTS playing a key role in dif-
ferential diagnostic work-up [135].
Although the current challenging clinical scenario makes 
serial invasive and not invasive diagnostic testing difficult, 
whenever possible multimodality imaging should be per-
formed in patients with SARS-CoV-2 and cardiac injury to 
distinguish type II myocardial infarction, myocarditis, and 
TTS, and to adopt the most appropriate therapeutic strategy.
Diagnostic algorithm and differential 
diagnosis
TTS is a complex clinical entity, with a wide spectrum of 
clinical presentations and varying levels of risk and haemo-
dynamic stability, which requires tailored management 
strategies depending on the different scenarios. Multimo-
dality imaging plays a key role in establishing the diagnosis, 
guiding therapy and stratifying prognosis in both the acute 
and post-acute phases of TTS (Figs. 20 and 21; Table 5). In 
clinical practice, echocardiography is the first-line imaging 
tool due to its widespread availability and feasibility in the 
acute care setting and the ability to easily and rapidly moni-
tor changes in cardiac function over time. In asymptomatic 
or paucisymptomatic patients, the detection of unexplained 
extended apical WMAs, despite mild ST-T changes at ECG 
and low troponin elevation, is highly suggestive of TTS 
diagnosis, especially if predisposing factors exist. Patients 
presenting with acute chest pain and/or dyspnoea, after ECG 
and first clinical evaluation, can be screened by the Inter-
TAK score. If the score is >70, echocardiographic findings 
Figure  18  Thallium scintigraphy (a and c) and cardiac SPECT 
images using 123I-BMIPP (b and d) in a 76-year-old female patient 
with takotsubo syndrome. A discrepancy is present between 
123I-BMIPP and perfusion uptake in the apical area. White arrows 
show decreased uptake of BMIPP in the apical area, compared with 
uptake of thallium. 123I-BMIPP, 123I-beta-methy-iodophenyl pentade-
canoic acid; SPECT, single-photon emission computed tomography
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compatible with apical or mid-ventricular ballooning, cir-
cumferential pattern and antegrade LAD flow, will orient the 
diagnosis towards TTS. In this case, coronary anatomy may 
be assessed invasively by CA or non-invasively by CCTA. 
Once CCTA and/or CA have confirmed the absence of cul-
prit atherosclerotic plaques, the patient should be hospital-
ized and monitored in the intensive care unit for at least 
48–72 h. TTE should be performed earlier in order to assess 
EF, cardiac output and, especially in unstable patients, to 
detect the onset of functional and mechanical complications 
(i.e. LVOTO, severe MR, and RV involvement). FU echo-
cardiography is recommended daily or every two or three 
days during the first weeks, and at longer intervals after the 
acute phase. TTE allows monitoring of the recovery of tran-
sient WMAs and can stratify patients into ‘low risk’ and 
‘high risk’, the latter requiring specific therapeutic measures. 
Being able to provide more detailed information about LV 
morphology and function, RV involvement, intraventricular 
thrombi, and pericardial effusion, CMR can be useful in the 
acute phase but its use is conditioned by the more limited 
availability, compared with echocardiography, and the dif-
ficulties in imaging unstable patients. Conversely, owing to 
its ability to detect the presence of oedema, a hallmark find-
ing in TTS diagnosis, CMR is crucial during the post-acute 
phase to rule out other common pathologies (e.g. ACS and 
myocarditis) (Table 6). It should be performed in doubtful 
cases or in patients with persistent WMAs, even after dis-
charge. Of note, recent studies have demonstrated that long-
term FU in TTS patients is not uneventful. Further studies 
are needed to verify if assessment of subclinical myocardial 
dysfunction by speckle tracking echocardiography and other 
more sophisticated nuclear techniques (e.g. SPECT-MIBG, 
PET) can help identify patients that may be more prone to 
develop recurrences, life-threatening arrhythmias, or heart 
failure phenotype.
Figure 19  Planar 123I-MIBG late images (a, c, e) and selected short-
axis slices (b, d, f) from SPECT late acquisition. (a, b) Reduced late 
heart to mediastinum ratio (1.3) and a clear apical defect on SPECT 
images. (c, d) Mild reduction of the heart to mediastinum ratio (1.5) 
and a slight apical defect on SPECT images. (e, f) Normal heart to 
mediastinum ratio (1.8) and normal distribution of radiotracer on 
SPECT images. 123I-MIBG, 123I-metaiodobenzyl-guanidine; SPECT, 
single-photon emission computed tomography. (Reprinted with per-
mission from Citro et al. [26])
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Figure  20  Diagnostic algorithm in patients with clinical suspicion 
of takotsubo syndrome at presentation. *Recommendations for inva-
sive coronary angiography and revascularization in non-ST-elevation 
acute coronary syndromes should be followed. ACS, acute coronary 
syndrome; CA, coronary angiography; CAD, coronary artery disease; 
CCTA, coronary computed tomography angiography; CMR, cardiac 
magnetic resonance; ECG, electrocardiogram; LAD, left anterior 
descending artery
Figure 21  Role of multimodality imaging during post-acute phase in 
patients with diagnosis of takotsubo syndrome. CAD, coronary artery 
disease; CMR, cardiac magnetic resonance; FU, follow-up; PET, 
positron emission tomography; SPECT, single-photon emission com-
puted tomography; TTS, takotsubo syndrome; WMAs, wall motion 
abnormalities
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